CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong.
Mike Wenger
Advertisement
Mike Wenger joined CRIO as Chief Innovation Officer in 2025, bringing nearly two decades of experience building solutions that improve patient engagement, streamline clinical trial operations, and enhance site efficiency. As founder of VersaTrial (acquired by Florence Healthcare), co-creator of TrialScope Connect (now Citeline Connect), and a technology strategist at the Michael J. Fox Foundation, Mike has pioneered innovative solutions that remove friction from research. At CRIO, he’s harnessing AI to eliminate administrative burdens so site teams can focus on what matters most—their patients—while advancing CRIO’s mission to reimagine clinical trials.
Articles by Mike Wenger
CRIO’s Mike Wenger, speaker at this year's SCRS summit, maps how sites are actually deploying AI post-pilot stage.
Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with proper oversight, and why advancing eSource and EHR systems remains critical to strengthening data integrity and remote trial operations.
Mike Wenger, chief innovation officer at CRIO, discusses how different site types—from academic medical centers to independent research sites—require distinct eSource approaches, and why aligning technology with site workflows is critical to study execution.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
4
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
5